Beta Bionics, Inc. (BBNX)
16.51
-1.30
(-7.30%)
USD |
NASDAQ |
Nov 12, 16:00
16.51
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Free Cash Flow (Quarterly) : -14.56M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -14.56M |
| June 30, 2026 | -15.66M |
| March 31, 2026 | -25.21M |
| December 31, 2025 | -10.53M |
| September 30, 2025 | -10.01M |
| June 30, 2025 | -15.37M |
| Date | Value |
|---|---|
| March 31, 2025 | -20.31M |
| December 31, 2024 | -14.84M |
| September 30, 2024 | -11.53M |
| June 30, 2024 | -12.74M |
| March 31, 2024 | -12.55M |
| December 31, 2023 | -6.66M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | -9.652M |
| Edwards Lifesciences Corp. | 506.70M |
| Intuitive Surgical, Inc. | 1.111B |
| Stryker Corp. | 1.224B |
| Zimmer Biomet Holdings, Inc. | 347.40M |